induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med. 5:774–779. 69. Sotomayor, E.M., I. Borrello, E. Tubb, F.M. Rattis, H. Bien, Z. Lu, S. Fein, S. Schoenberger, and H.I. Levitsky. 1999. Conversion of tumor-specific CD41 T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat. Med. 5:780–787. 70. Garza, K.M., S.M. Chan, R. Suri, L.T. Nguyen, B. Oder- matt, S.P. Schoenberger, and P.S. Ohashi. 2000. Role of an- tigen-presenting cells in mediating tolerance and autoimmu- nity. J. Exp. Med. 191:2021–2028. 71. Lefrancois, L., J.D. Altman, K. Williams, and S. Olson. 2000. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J. Immunol. 164:725– 732. 72. Ohteki, T., T. Fukao, K. Suzue, C. Maki, M. Ito, M. Naka- mura, and S. Koyasu. 1999. Interleukin 12–dependent inter- feron g production by CD8a1 lymphoid dendritic cells. J. Exp. Med. 189:1981–1986. 73. Randolph, D.A., G. Huang, C.J. Carruthers, L.E. Bromley, and D.D. Chaplin. 1999. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Sci- ence. 286:2159–2162. 74. Cyster, J.G. 2000. Leukocyte migration: scent of the T zone. Curr. Biol. 10:R30–R33. 75. Aliberti, J., C. Reis e Sousa, M. Schito, S. Hieny, T. Wells, G.B. Huffnagle, and A. Sher. 2000. CCR5 provides a signal for microbial induced production of IL-12 by CD8a1 den- dritic cells. Nat. Immunol. 1:83–87. 76. Sato, N., S.K. Ahuja, M. Quinones, V. Kostecki, R.L. Red- dick, P.C. Melby, W.A. Kuziel, and S.S. Ahuja. 2000. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)- inducing dendritic cells. Absence of CCR2 shifts the Leish- mania major–resistant phenotype to a susceptible state domi- nated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192:205–218. 1695 den Haan et al.